Travere Therapeutics to Present at Upcoming Investor Conferences
2024年8月7日 - 5:30AM
Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that
company management will present in the following upcoming investor
conferences in August:
2024 Wedbush PacGrow Healthcare
ConferenceTuesday, August 13, 2024, at 2:30 p.m. ET
Canaccord Genuity 44th
Annual Growth ConferenceWednesday, August 14,
2024, at 12:30 p.m. ET
A live webcast of the Canaccord Genuity 44th
Annual Growth Conference presentation will be accessible on the
Investor page of Travere’s website at
ir.travere.com/events-presentations, and a replay will be available
for up to 30 days following the event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for
life. We are a biopharmaceutical company that comes together every
day to help patients, families, and caregivers of all backgrounds
as they navigate life with a rare disease. On this path, we know
the need for treatment options is urgent – that is why our global
team works with the rare disease community to identify, develop,
and deliver life-changing therapies. In pursuit of this mission, we
continuously seek to understand the diverse perspectives of rare
patients and to courageously forge new paths to make a difference
in their lives and provide hope – today and tomorrow. For more
information, visit travere.com.
Contact:
Investors:888-969-7879 IR@travere.com |
Media:888-969-7879 mediarelations@travere.com |
Travere Therapeutics (NASDAQ:TVTX)
過去 株価チャート
から 9 2024 まで 10 2024
Travere Therapeutics (NASDAQ:TVTX)
過去 株価チャート
から 10 2023 まで 10 2024